Sqz BiotechnologiesÂ Co (SQZ) Financials

$0.05

$0.00 (8.09%)

As on 01-Sep-2023 09:30EDT

Market cap

$13 Mln

Revenue (TTM)

$15 Mln

P/E Ratio

--

P/B Ratio

0.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	15.33	21.03	27.10	21.00	19.32	12.67
Cost of Revenue	--	--	--	--	--	--
Gross Profit	15.33	21.03	27.10	21.00	19.32	12.67
Operating Expenses	82.96	96.85	95.87	72.06	53.58	31.94
Operating Profit (EBIT)	-72.49	-80.68	-68.77	-51.06	-34.27	-20.40
Other Income	0.46	--	0.03	0.54	--	--
Profit before Tax	-70.65	-79.46	-68.74	-50.52	-32.20	-19.25
Provision for Tax	-45.40	-1.22	-0.04	-0.55	-0.01	1.21
Profit after Tax (Net Income)	-25.59	-78.24	-68.71	-49.97	-32.20	-19.25
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-53.88	-79.46	-68.74	-50.52	-32.20	-20.23

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	24.54	57.15	123.98	127.20	-73.52	-43.54
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	19.70	20.91	68.95	58.75	187.58	137.76
Current Liabilities	9.91	21.84	33.22	45.19	38.28	21.33
Total Liabilities	64.06	99.90	226.15	231.14	152.35	115.55

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	26.46	31.70	75.52	54.31	50.53	6.73
Current Assets	27.69	68.20	150.64	176.83	101.82	108.81
Total Assets	64.06	99.90	226.15	231.14	152.35	115.55
Total Debt*	22.36	27.47	69.69	47.10	42.33	--
Net Current Assets	17.77	46.36	117.41	131.64	63.54	87.48

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-83.55	-82.14	-43.15	-33.49	21.10
Cash Flow from Investing Activities	--	-0.49	-0.61	57.82	-12.85	-36.96
Cash from Financing Activities	--	4.23	55.91	116.42	26.04	68.12
Net Cash Inflow / Outflow	--	--	-26.84	131.09	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-56.23	-37.34	-69.84	86.17	--
ROE (%)	-62.64	-86.40	-54.71	-186.17	55.01	--
ROA (%)	-18.74	-47.99	-30.05	-26.06	-24.04	--
EBIT Margin (%)	-472.99	-383.68	-253.78	-243.16	-177.37	-151.48
Net Margin (%)	-162.13	-372.08	-253.28	-232.05	-166.66	-151.95
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	-33.31	-0.22	0.29	0.09	0.52	--
EBIT Growth (%)	6.86	-17.33	-34.69	-49.01	-78.55	--
Net Profit Growth (%)	66.89	-13.88	-37.49	-55.21	-67.25	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.50	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.18	0.61	1.28	3.07	--	--
Close Price ($)	0.27	0.74	8.93	28.98	--	--
High Price ($)	3.56	10.86	31.04	160.00	--	--
Low Price ($)	0.25	0.65	8.69	12.98	--	--
Market Cap ($ Cr)	12.83	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.48	0.56	0.37	-0.58	--
Short term debt to equity ratio	0.11	0.11	0.08	0.06	-0.13	--
Current Ratio	2.79	3.12	4.53	3.91	2.66	5.10
Quick Ratio	2.79	3.14	4.54	3.92	--	--
Interest Coverage	-58.17	-8.30	-2,456.04	--	--	-325.27

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	1.83	11.42	11.63	10.79	9.88
Asset Turnover	0.11	0.13	0.12	0.11	0.14	--
Receivable days	--	30.21	37.32	39.36	31.54	36.10
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.